Latest Clinical Laserthermia Systems News & Updates

See the latest news and media coverage for CLS. We track all announcements, press releases, and industry mentions in real time, all in one place.

Clinical Laserthermia Systems (CLS)

Laser ablation systems for cancer care and neurosurgery

clinicallaser.se

Headquarters: Sweden
Company type: Public company
Number of employees: 20–50
Industry: Advanced Medical Equipment & Technology

Last updated Today

Latest news about Clinical Laserthermia Systems (CLS)

In short: CLS completed a SEK 31 million rights issue, appointed a permanent CFO, and secured FDA clearance for its neuro laser therapy system.

Company announcements

September 3 CLS

CLS authorizes a directed issue of shares and warrants

The transaction fulfills guarantee obligations to Vator Securities, increases share capital by approximately two percent, and could generate roughly SEK 24.7 million upon full warrant exercise.

August 31 CLS

Clinical Laserthermia Systems appoints Katarina Lundqvist as permanent CFO

She transitions from her interim consultancy role on September first while retaining her executive management team position and utilizing her extensive medtech financial expertise.

August 20 CLS

CLS raises approx SEK 31 million via rights issue to accelerate Prism business

The company received subscriptions for approximately 78.5 percent of the units, increasing share capital by SEK 1.6 million and issuing over 12 million warrants.

August 18 CLS

CLS signs top guarantee for order book issuance

The company secures the issuance with a top guarantee of approx. 7 MSEK from Vator Securities AB. In total, 78.5 percent of the volume is now covered by subscription and guarantee commitments.

Media coverage

July 29 Affärsvärlden

Monitoring of CLS rights issue begins

The medical technology company Clinical Laserthermia Systems has decided on a rights issue that could provide the company with SEK 39.5 million before expenses. Emissionsguiden begins its monitoring. ... The CLS board has...

May 12 FinanzNachrichten.de

Clinical Laserthermia Systems AB: CLS Publishes Interim Report January - March 2026

Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its interim report for January - March 2026. Highlights of First...

May 11 Dagens industri

CLS receives order worth 23 million

Clinical Laserthermia Systems, CLS, has received an order with a total value of approximately 23 million kronor for its neurosurgical Prism business from...

April 28 FinanzNachrichten.de

Clinical Laserthermia Systems AB: CLS Strengthens its Strategic Partnership in Neurosurgery and Aims to Become Market Leader in Neuro LITT

Clinical Laserthermia Systems AB (CLS) today announced it has reached an agreement with its strategic partner on an alignment to accelerate the growth of the...

Never miss news about CLS

Track CLS and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

CLS competitors & trending companies

Browse news for competitors to CLS and other trending companies.